Please provide your email address to receive an email when new articles are posted on . Dupilumab received FDA approval for treating adults with poorly controlled COPD with type 2 inflammation in ...
The researchers identified 411 patients with PMF who had baseline basophil and eosinophil counts available at the time of diagnosis or first referral. After a median follow-up of 52 months, most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results